Skip to main content

Year: 2022

Middle Market Companies Exhibit Resilience While Delivering Value

Ongoing investments in tech, talent and efficiencies remain strong CHARLOTTE, N.C., Oct. 13, 2022 (GLOBE NEWSWIRE) — AvidXchange (Nasdaq: AVDX), a leading provider of accounts payable (AP) automation software and payment solutions for middle market businesses and their suppliers, today released the next report in its Middle Market Spending Trends series. This report is based on data captured from the transactions processed in Q2 2022 through the company’s AvidPay Network. Additionally, AvidXchange surveyed ~500 middle market finance professionals on why and where they are spending in response to the current economic challenges. Research shows the middle market took its largest leap in spending, both quarterly and year-over-year, since 2017. And despite general concerns about the U.S. economy, 70 percent plan to increase the...

Continue reading

Hemp Inc. Applauds President Biden’s Plan to Pardon People Convicted of Simple Marijuana Possession

Las Vegas, NV, Oct. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp Inc. (OTC PINK: HEMP): On October 6, 2022, President Biden announced that he will pardon all prior federal offenses of simple possession of marijuana and will call on federal regulators to review how the drug is classified. The pardons will affect approximately 6,500 people convicted of federal offenses for simple possession from 1992 through 2021, as well as thousands of people in Washington D.C., according to senior administration officials. President Biden is also calling on governors to take similar actions. “Sending people to prison for possessing marijuana has upended too many lives and incarcerated people for conduct that many states no longer prohibit,” Mr. Biden said. “Criminal records for marijuana possession have also imposed needless barriers...

Continue reading

XBiotech Announces First Patient Enrolled into the French National Cancer Institute (INCA) Sponsored Phase I/II/III Clinical Study for Natrunix™ Therapy for Colorectal Cancer

INCA funded Phase I/II/III Study for Natrunix in Combination with Trifluridine/Tipiracil, the TASKIN Study, Launches at 20 Leading Medical Centers in France AUSTIN, Texas, Oct. 13, 2022 (GLOBE NEWSWIRE) — XBiotech (NASDAQ: XBIT) announced today the enrollment of the first patient in a multicenter, randomized clinical study for Natrunix in combination with trifluridine/tipiracil for the treatment of colorectal cancer. The much anticipated clinical study for XBiotech’s candidate cancer treatment is being funded by the French National Cancer Institute (INCA). The study is headed by renown oncologists Dr. François Ghiringhelli and Dr. Come Lepage, Professor in Medical Oncology and Director of the INSERM research team at the Georges-Francois Leclerc Cancer Centre, and Professor at the Department of Gastroenterology and Digestive Oncology,...

Continue reading

LEADING EDGE MATERIALS APPROVES CONTRACTOR TO OPEN BIHOR SUD ADITS

20221013 img1 Img120221013 img2 Img220221013 img3 Img320221013 img4 Img4Vancouver, October 13, 2022 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) is pleased to announce that the Company’s 51% owned Romanian subsidiary, LEM Romania SRL (“LEMR”), signed a General Works Contractor agreement (the “Agreement”) with Radioactive Mineral Magurele SA (“RMM”), a state owned company under the Ministry of Energy. RMM initial focus will be on the works needed to proceed with opening of historic mining galleries to enable underground exploration work over the winter season. RMM has decades of experience and expertise for exploration activities locally and has all necessary permits to perform those according to the highest technical and safety standards....

Continue reading

Publication of Healthcare Prospectus

Thames Ventures VCT 2 plc (“the Company”) LEI: 21380035MV1VRYEXPR95 13 October 2022 Publication of Healthcare Prospectus   The Company has today issued a prospectus (comprising a Securities Note, Registration Document and Summary) (the “Healthcare Prospectus”) relating to offers for subscription (“Offers”) by the Company to raise up to £10 million (with an over-allotment facility for up to a further £15 million) Healthcare Shares of 0.1p each following the approval of the Healthcare Prospectus by the Financial Conduct Authority.   The maximum number of shares that may be allotted under the Offers (including the over-allotment facility and shares to be allotted to management pursuant to performance incentive arrangements) is 40 million Healthcare Shares. Smaller Related Party Transaction Under the terms of the sponsor...

Continue reading

Yellow Corporation Schedules Third Quarter 2022 Earnings Conference Call

NASHVILLE, Tenn., Oct. 13, 2022 (GLOBE NEWSWIRE) — Yellow Corporation (NASDAQ: YELL) announced today that on Wednesday, Nov. 2, 2022, at 4:30 p.m. ET, company executives will host a conference call with the investment community to discuss third quarter 2022 results. The financial results will be released the same day, Nov. 2, 2022, after the market close. The call will be webcast and can be accessed live or as a replay via the Yellow Corporation website www.myyellow.com. About Yellow Corporation Yellow operates one of the largest, most comprehensive logistics and less-than-truckload (LTL) networks in North America, providing customers with regional, national, and international shipping services throughout. Backed by a team of over 30,000 transportation professionals, Yellow’s flexible supply chain solutions and best-in-class expertise...

Continue reading

CSC and Intertrust have obtained Regulatory Clearance in the Cayman Islands

JOINT PRESS RELEASE This is a joint press release by Intertrust N.V. (“Intertrust” or the “Company”) and CSC (Netherlands) Holdings B.V. (“CSC” or the “Offeror”) in connection with the recommended public offer (the “Offer”) by the Offeror for all the issued and outstanding ordinary shares in the capital of Intertrust. This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Intertrust. Any offer will be made only by means of the offer memorandum (the “Offer Memorandum”) approved by the Dutch Authority for Financial Markets (Stichting Autoriteit Financiële Markten, the “AFM”) which was published on 31 March 2022, and subject to the restrictions set forth therein. With reference to the joint...

Continue reading

TowneBank Promotes Morrison and Miller

William T. Morrison President and Chief Executive Officer, Towne Financial Services GroupJames M. Miller President and Chief Executive Officer, TowneBank MortgageSUFFOLK, Va., Oct. 13, 2022 (GLOBE NEWSWIRE) — TowneBank (the “Company” or “Towne”) (Nasdaq: TOWN) announced today the promotions of William T. Morrison to president and chief executive officer of Towne Financial Services Group and James M. Miller to chief executive officer of TowneBank Mortgage. The moves come as part of the Company’s new board-approved leadership succession plan. As head of Towne Financial Services Group, Morrison will oversee the Company’s non-banking lines of business, including residential mortgage, insurance, real estate brokerage, wealth management, and vacation property management. He also will join Towne’s Corporate Management Group, which...

Continue reading

Volta Finance Limited – Net Asset Value as at 30 September 2022

Volta Finance Limited (VTA / VTAS) – September 2022 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES ***** Guernsey, 13 October 2022 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for September. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com). PERFORMANCE and PORTFOLIO ACTIVITY This month, the structured debt market has been significantly impacted by the “liquidity” crunch resultating in the Volta net asset value (“NAV”) declining by -7.2%, totally reversing the +7.2% NAV uplift seen in July/August. Examining the underlying sub asset classes, the monthly performances** were: +1.3% for Bank Balance Sheet transactions, -5.6% for CLO equity tranches; -8.7%...

Continue reading

Voltalia commissions its largest solar plant

Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energy, announces that it has completed the full commissioning of SSM1&2. Located in the Serra Branca cluster in the Brazilian state of Rio Grande do Norte, it is now Voltalia’s largest solar project in the world with a capacity of 320 megawatts. “The commissioning of SSM1-2 is a great achievement. I would like to warmly thank all the Voltalia teams, as well as the suppliers and subcontractors, who have been working together on this 320 megawatt photovoltaic project. Their work continues with the adjacent 260 megawatt SSM3-6 project, which began in March 2022,” said Sébastien Clerc, CEO of Voltalia. The construction of the 320 megawatt SSM1-2 solar plant is finishing its final completion tests with its final works. Construction...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.